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Abstract 
Leptospirosis is presumed to be most widespread zoonosis in the world. 
This study was carried out to investigate the zoonotic importance of  
leptospirosis by examination of two groups of patients: renal failure patients 
and patients came to the different clinics with different clinical 
manifestations. 
One hundred and twenty urine samples were collected from renal 
failure patients from different dialysis centers in Sudan. All samples were 
examined bacteriologically for leptospiral growth, 16 (13.3%) samples 
revealed leptospiral growth. 
Indirect Enzyme-Linked Immunosorbent Assay (ELISA) was used to 
demonstrate antibodies to leptospires. From one hundred and fifty serum 
samples collected from renal failure patients, IgG to leptospires was 
demonstrated in 18 (12%) samples. On the other hand from 149 serum 
samples collected from random patients came to the clinic with different 
clinical manifestations, IgM to leptospires was detected in 63 (42.3%) 
sample, while from 132 serum samples examined from the same group, IgG 
 vi
to leptospires was detected in 9(6.8%). The overall prevalence of 
leptospirosis among tested patients from the two groups was 84 (28.09%)   
         Polymerase Chain Reaction (PCR) was performed to detect leptospiral 
DNA from collected urine & serum samples using one pair of specific 
primers. The following results were obtained: Out of 120 urine samples 
collected from renal failure patient, the DNA from 2 urine samples was 
amplified and produced single bands with molecular size of 274 base pairs 
(bp). While none of 150 sera collected from the same group of patients 
showed positive results with PCR. On the other hand, out of 149 sera 
collected from patients came to the clinic with different clinical 
manifestations, the DNA from 8 samples was amplified and produced single 
bands with molecular size of 274 bp. 
 There was no significant difference between occurrences of 
leptospirosis within the two groups of the patients and many factors (area, 
sex, age, occupation and contact with animals). 
In conclusion, human leptospirosis is endemic infection in studied 
groups of patients, moreover, it is clear that the disease could be considered 
as one of the causes of human renal failure in Sudan.  
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 ﺑﺴﻢ اﷲ اﻟﺮﺣﻤﻦ اﻟﺮﺣﻴﻢ 
 
 ﺧﻼﺻﺔ اﻷﻃﺮوﺣﺔ
  .ﻣﻦ اﻟﻤﺴﺎم ﺑﻪ أن داء اﻟﺒﺮﻳﻤﻴﺎت ﻣﻦ أآﺜﺮ اﻷﻣﺮاض  اﻟﻤﺘﻨﺎﻗﻠﺔ واﺳﻌﺔ اﻻﻧﺘﺸﺎر ﻓﻲ اﻟﻌﺎﻟﻢ  
أﺟﺮﻳﺖ هﺬﻩ اﻟﺪراﺳﺔ ﻟﺘﻘﺼﻲ أهﻤﻴﺔ آﻮن اﻟﻤﺮض ﻣﺮﺿﺎ ﻣﺘﻨﺎﻗﻼ ﺑﻴﻦ اﻹﻧﺴﺎن و اﻟﺤﻴﻮان ﻓﻲ   
ﻟﻤﺠﻤﻮﻋﺔ اﻷﺧﺮى ﺗﻤﺜﻞ ﻣﺠﻤﻮﻋﺔ ﻣﺠﻤﻮﻋﺔ ﺗﻤﺜﻞ ﻣﺮﺿﻰ اﻟﻔﺸﻞ اﻟﻜﻠﻮي و ا: ﻣﺠﻤﻮﻋﺘﻴﻦ ﻣﻦ اﻟﻤﺮﺿﻰ
  .ﻣﻦ اﻟﻤﺮﺿﻰ ﻗﺪﻣﻮا ﻟﻠﻤﺴﺘﺸﻔﻰ ﺑﺄﻋﺮاض ﻣﺨﺘﻠﻔﺔ( ﻋﺸﻮاﺋﻴﺔ)
 ﻋﻴﻨﺔ ﺑﻮل ﺗﻢ ﺟﻤﻌﻬﺎ ﻣﻦ ﻣﺮﺿﻰ اﻟﻔﺸﻞ اﻟﻜﻠﻮي ﻣﻦ ﻣﺨﺘﻠﻒ ﻣﺮاآﺰ اﻹﺳﺘﺼﻔﺎء اﻟﺪﻣﻮي 021  
  .ﻓﻲ اﻟﺴﻮدان
  .ﻋﻴﻨﺔ أﻇﻬﺮت ﻧﻤﻮا ﻟﻠﺒﺮﻳﻤﻴﺎت%( 3.31 )61, آﻞ هﺬﻩ اﻟﻌﻴﻨﺎت اﺧﺘﺒﺮت ﺟﺮﺛﻮﻣﻴﺎ  
 051ﻻﺧﺘﺒﺎر وﺟﻮد اﻷﺟﺴﺎم اﻟﻤﻀﺎدة اﻟﻤﻨﺎﻋﻴﺔ ﻟﻤﺮض اﻟﺒﺮﻳﻤﻴﺎت ﻋﻠﻰ أﺟﺮي اﺧﺘﺒﺎر اﻷﻟﻴﺰا   
 81ﻓﻲ ( G) ﻋﻴﻨﺔ ﻣﺼﻞ ﺟﻤﻌﺖ ﻣﻦ ﻣﺮﺿﻰ اﻟﻔﺸﻞ اﻟﻜﻠﻮي و ﻗﺪ وﺟﺪت اﻷﺟﺴﺎم اﻟﻤﻀﺎدة ﻣﻦ اﻟﻨﻮع 
 ﻋﻴﻨﺔ ﻣﺼﻞ ﺟﻤﻌﺖ ﻣﻦ اﻟﻤﺮﺿﻰ اﻟﺬﻳﻦ دﺧﻠﻮا اﻟﻤﺴﺘﺸﻔﻰ 941و ﻣﻦ , ﻣﻦ ﺟﻬﺔ أﺧﺮى . ﻋﻴﻨﺔ%( 21)
%( 3.24 )36ﻓﻲ ( M)ﻀﺎدة ﻟﻤﺮض اﻟﺒﺮﻳﻤﻴﺎت ﻣﻦ اﻟﻨﻮع ﺑﺄﻋﺮاض ﻣﺨﺘﻠﻔﺔ ﻓﻘﺪ وﺟﺪت اﻷﺟﺴﺎم اﻟﻤ
ﻓﻲ ﻧﻔﺲ اﻟﻤﺠﻤﻮﻋﺔ ﻣﻦ ( G)ﺑﻴﻨﻤﺎ وﺟﺪت اﻷﺟﺴﺎم اﻟﻤﻀﺎدة ﻟﻤﺮض اﻟﺒﺮﻳﻤﻴﺎت ﻣﻦ اﻟﻨﻮع . ﻋﻴﻨﺔ
  .ﻋﻴﻨﺔ%( 8.6)اﻟﻤﺮﺿﻰ ﻓﻲ 
 ﻓﻲ اﻟﻤﺠﻤﻮﻋﺘﻴﻦ ﻣﻦ اﻟﻤﺮﺿﻰ آﺎن  M , Gاﻟﻮﺟﻮد اﻟﻤﺠﻤﻞ ﻟﻸﺟﺴﺎم اﻟﻤﻀﺎدة ﻣﻦ اﻟﻨﻮﻋﻴﻦ   
  %(.9.82 )48
ﺎﻋﻞ اﻟﺒﻮﻟﻴﻤﻴﺮي اﻟﻤﺘﺴﻠﺴﻞ ﻟﺘﺤﺪﻳﺪ وﺟﻮد اﻟﺤﻤﺾ اﻟﻨﻮوي ﻣﻨﻘﻮص اﻷآﺴﺠﻴﻦ أﺟﺮي اﺧﺘﺒﺎر اﻟﺘﻔ  
  .ﻓﻲ ﻋﻴﻨﺎت اﻟﺒﻮل و اﻟﻤﺼﻞ ﺑﺎﺳﺘﻌﻤﺎل زوج واﺣﺪ ﻣﻦ اﻟﺒﺮاﻳﻤﺮ اﻟﺨﺎﺻﺔ
 ﻋﻴﻨﺔ ﺑﻮل ﺟﻤﻌﺖ ﻣﻦ ﻣﺮﺿﻰ اﻟﻔﺸﻞ اﻟﻜﻠﻮي ﺗﻢ إآﺜﺎر اﻟﺤﻤﺾ اﻟﻨﻮوي ﻣﻨﻘﻮص 021ﻣﻦ   
ﺑﻴﻨﻤﺎ ﻟﻢ ﺗﻮﺟﺪ ,  ﻗﺎﻋﺪة ﺛﻨﺎﺋﻴﺔ472اﻷآﺴﺠﻴﻦ ﻓﻲ ﻋﻴﻨﺘﻴﻦ و ﻗﺪ ﻧﺘﺠﺖ ﺣﺰم ﻓﺮادﻳﺔ ﺑﺤﺠﻢ ﺟﺰﻳﺌﻲ ﻣﻘﺪارﻩ 
ﻣﻦ .  ﻋﻴﻨﺔ ﻣﺼﻞ اﻟﺘﻲ ﺟﻤﻌﺖ ﻣﻦ ﻧﻔﺲ اﻟﻤﺠﻤﻮﻋﺔ051ﻋﻴﻨﺔ ﻣﻮﺟﺒﺔ ﻟﻠﺘﻔﺎﻋﻞ اﻟﺒﻮﻟﻴﻤﻴﺮي اﻟﻤﺘﺴﻠﺴﻞ ﻣﻦ 
 ﻋﻴﻨﺎت ﻣﺼﻞ ﺟﻤﻌﺖ ﻣﻦ ﻣﺠﻤﻮﻋﺔ 8ﺟﻬﺔ أﺧﺮى ﺗﻢ إآﺜﺎر اﻟﺤﻤﺾ اﻟﻨﻮوي ﻣﻨﻘﻮص اﻷآﺴﺠﻴﻦ ﻓﻲ 
 ﻗﺎﻋﺪة 472اﻟﻔﺮادﻳﺔ  و آﺎن اﻟﺤﺠﻢ اﻟﺠﺰﻳﺌﻲ ﻟﻠﺤﺰم 941اﻟﻤﺮﺿﻰ ﻣﺨﺘﻠﻔﻲ اﻷﻋﺮاض اﻟﺒﺎﻟﻎ ﻋﺪدهﻢ 
  .ﺛﻨﺎﺋﻴﺔ
ﺑﺎﺳﺘﻌﻤﺎل ﺗﻘﻨﻴﺔ )وﺟﺪ أﻧﻪ ﻻ ﺗﻮﺟﺪ أهﻤﻴﺔ ذات ﻣﻐﺬى إﺣﺼﺎﺋﻲ ﺑﻴﻦ ﺣﺪوث داء اﻟﺒﺮﻳﻤﻴﺎت   
اﻟﻤﻬﻨﺔ و , اﻟﻌﻤﺮ, اﻟﺠﻨﺲ, داﺧﻞ اﻟﻤﺠﻤﻮﻋﺘﻴﻦ ﻣﻦ اﻟﻤﺮﺿﻰ و ﺑﻌﺾ اﻟﻌﻮاﻣﻞ ﻣﺜﻞ اﻟﻤﻜﺎن( اﻷﻟﻴﺰا
  .اﻻﺣﺘﻜﺎك ﺑﺎﻟﺤﻴﻮاﻧﺎت
.  ﻣﺠﻤﻮﻋﺔ اﻟﻤﺮﺿﻰ اﻟﺘﻲ درﺳﺖو ﺧﻼﺻﺔ ﻓﺈن داء اﻟﺒﺮﻳﻤﻴﺎت ﻓﻲ اﻹﻧﺴﺎن ﻣﺘﻮﻃﻦ ﻓﻲ  
ﺑﺎﻹﺿﺎﻓﺔ إﻟﻲ ذﻟﻚ أﺗﻀﺢ أن اﻟﻤﺮض ﻳﻤﻜﻦ اﻋﺘﺒﺎرﻩ آﻮاﺣﺪ ﻣﻦ أﺳﺒﺎب اﻟﻔﺸﻞ اﻟﻜﻠﻮي ﻓﻲ اﻹﻧﺴﺎن ﻓﻲ 
  .اﻟﺴﻮدان
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INTRODUCTION 
Leptospirosis, also known as “mud fever” and “march fever” is an 
important zoonotic disease, with important veterinary and public health 
impact (Dikken and Kemty, 1978; Gussenhoven et al., 1997; Marcos et al., 
1997). Leptospirosis is caused by Leptospira interrogans. Based on 
immunological tests, more than 200 leptospiral serovars have been 
identified. The serovars could be placed into 23 serogroups (Soltys, 1979; 
Woodward et al., 1997; Chu et al., 1998). 
In livestock, the disease causes important economic losses. Although 
this disease is usually mild and often subclinical, it can lead to great losses 
due to abortions, stillbirths, infertility, mastitis, week progeny, decreased 
milk production and with certain leptospiral serovars, death (Songer et al., 
1983; Thiermann, 1984; Bey and Johnson, 1986). 
Leptospiral serovars can infect mammals including man. However, the 
pathogenecity and clinical manifestations of the disease depend on the 
animal host and infecting serovar. It is evident that the epidemiology of 
leptospirosis involves wildlife, mainly rodents which are the important 
factors in the maintenance and spread of the disease to livestock and humans 
 2
(Cirone et al., 1978). Worldwide, most human cases of leptospirosis are 
attributed to rodents. Additionally, leptospires have been isolated from birds, 
reptiles, amphibians and arthropods (Gordon, 1977; Miller et al, 1991). 
All human cases of leptospirosis are contracted directly or indirectly 
from animals. Leptospires shed in the urine of infected animals contaminate 
the environment (soil, water, food, bedding, etc.). This contaminated 
environment will be potential source of infection to other animals and 
humans (Gordon, 1977). 
Generally, the disease is more prevalent in areas where the climate is 
warm and humid, soils are alkaline and where there is heavy rainfall with 
consequences of abundance of surface water and stagnant pools (Joseph, 
1979). Hence the disease is of high prevalence in tropical regions due to 
favorable environment and climatic factors. Leptospirosis is a common acute 
febrile human disease in tropical climates and must be differentiated from 
typhoid, malaria, dengue, viral hepatitis and other parasitic and viral 
infections when these diseases are present in the population. Only 30% of 
patients with leptospirosis were correctly diagnosed (Bey and Johnson, 
1986; Weekes et al., 1997; Chu et al., 1998). 
The wide spectrum of clinical symptoms makes the diagnosis of human 
leptospirosis very difficult. The course of the disease varies from mild to 
 3
rapidly fatal form. Therefore, laboratory-defined dignosis is essential for 
effective therapy and epidemiological surveys (Faine, 1982; Perolat et al., 
1994). Economic losses due to leptospirosis in the domestic animals and the 
possibility of transmission to man stress the importance of diagnostic 
techniques which aid in establishing actual and effective control measures. 
The diagnosis of leptospirosis based on serology is the most suitable for 
the rapid testing of large number of individuals (Cole et al., 1973; 
Worthington, 1982; Rance et al., 1987; Gussenhoven et al., 1997). Different 
types of ELISA have been developed and used. They were found to be 
quick, sensitive, easy and reproducible method for diagnosis of leptospirosis 
(Adler et al., 1980; Terpstra et al., 1983; Pappas et al., 1985; Silva et al., 
1997; Brandao et al., 1998). 
Recently, DNA based techniques have been introduced in the field of 
leptospirosis. They have been demonstrated to provide a useful addition and 
alternative methods in identification of leptospiral strains and diagnosis of 
the disease (Thiermann et al., 1985; Van Eys et al., 1988). With the 
introduction of polymerase chain reaction (PCR), rapid detection of a small 
number of leptospires in clinical samples may become practical due to 
specific amplification of leptospiral DNA (Gravekamp et al., 1993). 
The main objectives of this study were: 
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1. To investigate leptospirosis among renal failure patients.   
2. To investigate leptospirosis among random patients came to the clinic 
with different clinical manifestations.  
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CHAPTER I 
LITERATURE REVIEW 
1.1. Leptospires 
Leptospires are members of the family Treponemataceae. Noguchi 
(1971) recognized leptospires as a separate genus and differentiated them in 
one morphological basis from the genera Borrelia and Treponema. 
Leptospires are thin, flexible, filamentous (0.1 to 0.2µm width & 6 to 
12 µm length) bacteria made up of fine spirals with hook–shaped ends. They 
are composed of a protoplasmic cylinder that is wound around straight 
central axial filaments. The outer envelope is composed of lipopolysacharide 
and antigenic mucopeptide. The composition of the lipopolysacharide is 
similar to that of other Gram–negative bacteria, but it has a lower indotoxic 
activity. 
Leptospire are motile, making writhing and flexing movement while 
rotating along their long axis (Cathy and Kerry 2003). 
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Leptospire are unique among spirochetes, because they have terminal 
hooks. A helically shaped cell cylinder and two periplasmic flagella enable 
the organism to burrow into tissue (Farr, 1995). 
 The organisms are not seen by the ordinary light field microscopy but 
can be observed clearly by the dark field microscopy. The cells are not 
easily visualized after staining by the aniline dyes, but they can be 
demonstrated by silver-deposition technique. 
 The taxonomy and classification of these organisms are varied and 
complex. Before 1989 the genus Leptospira was divided into two species: 
Leptospira interrogans and Leptptospira biflexa. L. interrogans is the only 
pathogenic species, and it is distributed worldwide in approximately 160 
mammalian species. Within L .interrogans alone, there have been over 200 
serovars recognized (Greene. et al., 1998). 
 Recently, molecular taxonomic studies showed that members of 
L.interrogans could be grouped into eight species (Letocard et al., 1997). 
 The free-living (L.biflexa) and parasitic leptospire (L.interrogans) are 
indistinguishable morphologically (Faine, 1982). 
 Currently more than 200 leptospiral serovars have been described. 
They are placed into 23 serogroups according to the extent of antigenic 
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cross-activity between serovars (Soltys, 1979; Hathaway et al., 1983; 
Gussinhoven et al., 1997; Woodward et al., 1997)  
The current method for identification of leptospiral serovars is by the 
cross agglutination absorption but this method did not differentiate between 
strains within the serovars (Hathaway et al.,1985). Recently, DNA–based 
techniques were introduced to identify leptospiral serovars and even they 
could differentiate between the strains (Marshall et al., 1981; Van Eys et al., 
1991; Pacciarini et al., 1992; Djordjevic et al., 1993; Comey and Colley, 
1996) 
1.2. Leptospirosis 
1.2.1. Epidemiology  
Leptospirosis is presumed to be most widespread zoonosis in the world 
(WHO.1999).  The source of infection in human is usually either direct or 
indirect contact with the urine of infected animals. Infection due to handling 
of infected animal tissues or aborted fetuses may occur (Faine, 1982; Yersin 
et al., 1999). Direct transmission between human has been demonstrated 
rarely. However, excretion of leptospire in human urine months after 
recovery has been recorded (Johnson, 1950; Bal et al., 1994). It is thought 
that the low pH of human urine limits survival of leptospire after excretion. 
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Transmission by sexual intercourse during convalescence has been reported 
(Doeleman. 1932; Harrison and. Fitzgerald. 1988). 
 In most areas of the world, Leptospirosis is primary an occupational 
disease. Generally the groups at risk are veterinarian, abattoir workers 
(Hathaway et al., 1985; Chan et al., 1987; Campagnolo et al., 2000), meat 
inspectors (Blackmore  et al., 1979), agricultural workers, sewers and mine 
workers and other wet rodent-infested environment workers (Faine, 1982). 
Distinct high-risk groups of leptospirosis are workers in livestock farms and 
slaughterhouse (Heath and Johnson, 1994). Home-acquired infections are 
due to exposure to infected pet animals or rodent-infested environment. 
Leisure activity like swimming and fishing may also present risk of infection 
(Robertson et al., 1981). Persons of all ages and sexes are susceptible to 
infection (Tan, 1973; Yersin et al., 1998).  
 The usual portal of entry is through abrasions or cuts in the skin or via 
the conjunctiva; infection may take place via intact skin after prolonged 
immersion in water. Water-borne transmission has been documented; point 
contamination of water supplies has resulted in several outbreaks of 
leptospirosis. Inhalation of water aerosols also may result in infection via the 
mucous membranes of the respiratory tract. Rarely infection my follow 
animal bites (Barkin et al., 1974; de Souza. 1986; Gollop et al., 1993). 
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 There is an evidence that spirochete survives in insects and other 
invertebrate’s hosts, but the significance of this finding with regard to 
disease transmission is unknown. Once out side the host, leptospires do not 
replicate (Greene et al., 1998). Depending on the condition, however, 
leptospire may remain viable for months when environmental factors are 
optimal (Greene, 1998; Levett, 2001). The optimal survival condition for 
leptospires is a warm, wet environment with neutral to slightly alkaline 
stagnant or slow- moving water. Hence, the disease tends to be seasonal in 
temperate climate, with peak incidence occurring when weather permits, and 
year-around in tropical climates (Adin et al., 2000; Ward, 2002). In arid 
areas or during drought conditions, infection of accidental hosts is more 
common around water sources. Raw sewage or other similar contamination 
will decrease the survival time of leptospires. Optimum survival in soil 
favored by a neutral or slightly alkaline pH. Spirochetes survive only 
transiently in undiluted acidic urine (pH 5.0 to 5.50), whereas the opposite 
condition provides more suitable habitats. Ambient temperature between 
0°C and 25°C favor the survival and replication of leptospires, whereas 
freezing markedly decrease survival (Greene et al., 1998; Birnbaum et al., 
1998; Ward, 2002).               
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1.2.2. Transmission  
Leptospirosis is transmitted by direct contact or by exposure to 
infective materials in the environment that permits survival of the leptospires 
(Ellis, 1986; Merien and Perolat, 1996). Susceptible hosts can become 
infected through mucous membranes or abraded skin. Generally, man 
contacts the infection when he is being exposed to the leptospire in the 
ecosystem or when he is involved in an occupation related to animals or 
disease-infected environment. The animal species, which maintain the 
organism in their kidneys, act as chronic carriers. They are able to shed the 
leptospires in their urine for long period, which may last more than one year 
(Thiermann, 1984; Leonard et al., 1992). The important animal species that 
act as reservoirs of infection are rodents, cattle, pigs and dogs (Everard et 
al., 1979). Recently the animal industry becomes highly developed and 
increased stocking rates were practiced especially in dairy cattle. This may 
contribute to an increase in animal as well as human leptospiral infection. In 
animals, venereal transmission of leptospirosis has been shown to occur with 
natural or artificial insemination (Sleight and Williams, 1961)      
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1.2.3. Pathogenesis  
  Knowledge on pathogenesis and course of leptospirosis is essential in 
the selection of the specimens for appropriate diagnosis and understanding 
of the clinical features. Measures on control and prevention depend on this 
information.  
Leptospiral serovars vary in their pathogenecity and host specificity 
(Van, 1967). Generally, disease type and course of infection are similar in all 
animals as well as man (Turner, 1967). 
Leptospires penetrate mucous membranes or abraded skin and multiply 
rapidly upon entering the blood. Then they spread and further replicate in 
many tissues including the kidneys, liver, spleen, central nervous system 
(CNS), eyes and genital tract. Increase in serum antibodies thereafter clear 
the spirochete from most organs, but organisms may persist in the kidney 
and be shed in the urine for weeks or months. The extent of damage to 
internal organs varies with virulence of the organism and host susceptibility. 
Certain serovars have the tendency to produce acute hemorrhagic, hepatic, 
or most commonly, renal dysfunction. More than one form may occur in a 
given animal, and the clinical manifestation can vary among outbreaks and 
geographic areas with given serovars. The mechanisms by which leptospires 
cause diseases are not well understood. Toxins and enzymes produced by 
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leptospires may contribute to their pathogenecity. The clinical and 
pathological features of infection have suggested the presence of endotoxins 
(Cathy and Kerry 2003). 
Leptospiral lipopolysacharide stimulates neutrophils adherence and 
platelets activation, which may be involved in inflammatory and coagulatory 
abnormalities. Several laboratories recently have isolated a 
lipopolysacharide-like substance, but this has not been shown to contribute 
to the pathogenesis of leptospirosis. (Farr, 1995). Toxins that may be 
heamolysins have been isolated in some strains. (Levett, 2001).  
  Leptospirosis causes a severe vasculitis with endothelial damage, 
resulting in injury to capillaries, tissue edema, hemorrhagic diathesis, and 
potentially disseminated intravasicular coagulation (DIC). 
 Renal insufficiency and failure are the result of tubular damage associated 
with colonization and replication of the organism in the renal tubular 
epithelial cells (Farr, 1995). Acute impairment of renal function also may 
result from decreased glomerular filtration and hypoxia caused by kidney 
swelling that impairs renal blood perfusion (Greene et al., 1998). 
Hypovolemia and hypotension may occur in severe cases as a result of 
dehydration, massive hemorrhage, vasculitis, myocarditis, pericarditis and 
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cardiac dysrhythmias are well-documented manifestations of leptospirosis 
that can lead to hypo perfusion (Farr, 1995). 
  Hepatic involvement manifested most commonly as icterus though 
decreased serum albumin levels, increased globulin levels, and impaired 
production of vitamin K-dependent clotting factor also are seen. Focal 
hepatocellular necrosis is the most common histopathological change. 
Results of histochemical studies suggest that the fundamental hepatic lesion 
is caused by sub cellular effect on enzyme system (Farr, 1995). The degree 
of icterus in human leptospirosis usually corresponds to the severity of 
hepatic necrosis. 
  Central Nervous System involvement in people most commonly 
manifested as aseptic meningitis (Panicker, 2001). Leptospire enter the 
cerebrospinal fluid (CSF) in the early septicemic phase of the illness. The 
meningeal sign often appear in second week of illness, when the leptospire 
are being cleared from the (CSF) and antigen-antibody complex include 
inflammation may be responsible for the symptoms (Levette, 2001; Panicker 
at al., 2001). 
1.2.4. Immunity  
Cell mediated immunity is less important than humeral immunity in 
leptospiral infection. (Thermann, 1984; Heath and Johnson, 1994). After 
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entering the body, the leptospire multiply in the blood and persist until they 
are cleared following the production of leptospira-specific antibodies. In 
humans, antibodies to leptospire become detected at about the seventh day 
of illness. At this stage, the leptospires remain in the convoluted tubules of 
the kidneys. 
  In various animal species and humans, IgM is the first 
immunoglobulin that can be detected following antigenic stimulation. It is 
followed by the appearance of IgG some times later. As a rule, the IgG 
continues for a more prolong period than does the IgM, which usually 
decrease within a few weeks (Pike, 1967; Crawford, 1972). Initially, IgM 
antibodies directed at serovars-specific and non serovars-specific antigens 
on the external sheath of the spirochetes. This would retard the growth of 
leptospires, but would not kill them. After several days, IgG antibodies 
cause lysis of circulating leptospires (Heath and Johnson, 1994). It has been 
established in man and in a number of animals that not IgM alone, but, also 
to a lesser extent IgG too will cause agglutination of particle antigen 
(leptospires) (Pike, 1967; Crawford, 1972; Bey and Johnson, 1978; Adler 
and Faine, 1978). Leptospires may evade the immune system becoming 
sequestered in the renal tubules or in immunologically protected tissues such 
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as eyes and brain. Leptospires sequestered in renal tubules are voided in 
urine. 
Cross-protection among serovars does not develop after vaccination 
and clinically unimportant after natural exposure (Heath and Johnson, 1994). 
Studies by Pike et al., 1965 and tong et al. (1971) on small number of 
patients showed that predominant agglutinated antibody was 
immunoglobulin M (IgM). In one patient, IgM agglutinins still 
predominated in serum taken 2 months after the onset of the illness. Tong et 
al. (1971) found that no antibody could be shown by Microscopic 
Agglutination Test (MAT) or complement fixation test in the IgG fraction of 
serum samples taken up to three weeks after the onset of illness in three 
cases. 
Sulzer et al. (1975). Found that 42 out of 229 sera positive for 
leptospirosis contained IgG, using sensitivity to 2-meracaptoethanol as a 
measure of the contribution by the IgM to serum agglutinations. Adler et al. 
(1980) examined culture-proven cases of human leptospirosis and found 
that, although IgM was predominant, some patients did not produce IgG 
agglutinins. On the other hand, in some patients only IgM agglutinins were 
detected even several months after infection. 
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Adler and Faine (1978) studied antibody response in human patients 
from whom Leptospira interrogans was isolated. It was observed that the 
antibodies involved in leptospiral agglutination were mainly IgM, but some 
patients also produced IgG agglutinins. The titers of IgM agglutinins were 
higher than those of IgG agglutinins and persisted for many months. The 
behavior of specific IgM, IgG and IgA was demonstrated by Silva et al. 
(1997). Two groups of patients in acute and convalescence stage were 
studied. IgM class antibodies were detected starting on the second day of 
infection and were observed in all patients up to 5th month, in 66.7% of the 
patients up to the 7th month and in 50% of the patient up to the 12th month 
after the onset of symptoms. IgG class of antibodies was first detected on the 
7th day of symptoms in 9.1% of patients, with maximum reactivity (87.5%) 
between the second and third month. IgA class of antibodies were detected 
from the 5th day of symptoms in 7.7% of patients and in all patients on the 
15th day, persisting in 100% of cases up to 9th follow up month. During the 
12th month IgA class antibodies were observed in 83.3% of patients. 
1.2.5. Clinical Signs and Symptoms 
Leptospirosis is a disease with a number of possible clinical 
presentation and course (Feigin and Anderson, 1975). The clinical 
manifestations are varied. Leptospirosis usually presents as a mild illness 
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with fever, myalgia and headache. The disease can progress to Weil`s 
syndrome, a severe debilitating infection with liver dysfunction, acute renal 
failure and microvascular hemorrhage. The mortality rate from untreated 
Weil`s syndrome is 5%-30% (Chu et al., 1998; Yersin et al., 1998). Overt 
clinical manifestations can be occasionally absent in leptospiral infection. In 
other cases, clinical symptoms vary between mild, almost inapparent illness, 
and acute febrile disease with a fatal outcome (Riberio et al., 1992). Signs of 
meningitis are common in human leptospirosis, and this form of leptospiral 
infection can easily mistaken for aseptic meningitis (Romero et al., 1998). 
On studying 28 patients, Merien et al., (1995) found that the main clinical 
manifestations exhibited by the said patients with leptospirosis were fever 
(85.7%), myalgia (60.7%), headache (60.7%), jaundice (31.0%), and 
meningeal syndrome (20%). Additional manifestations were conjuctival 
suffusion (17.8%), pulmonary syndrome (14.3%), hemorrhage (7%), renal 
syndrome (17.8%) and cardiac arrhythmia (3.5%). Patient suspected of acute 
leptospirosis examined by Yersin et al. (1999) showed fever and/or myalgia, 
tender liver, jaundice, acute renal failure, bleeding tendency, meningism and 
radiological lung infiltrate. 
Tan (1964) stated that leptospirosis was common in Malaysia and the 
disease can be mild. Analysis of 173 cases of leptospirosis indicated that 
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fever is a common manifestation and appeared in all cases examined. 
Muscle pain, conjuctival injection and muscle tenderness were observed. 
The finding showed 2 cases of encephalitis. 
Leptospirosis in human may show a wide variety of symptoms and 
signs including: fever, severe headache, myalgias, conjuctival suffusion, 
jaundice, general malaise, stiff neck chills, abdominal pain, joint pain, 
anorexia, nausea, vomiting, diarrhea, oliguria/anuria, hemorrhages, skin 
rash, photophobia, cough, cardiac arrhythmia, hypotension, mental 
confusion, psychosis and delirium. (WHO, 2003a).  
1.2.6. Laboratory Diagnosis 
Accurate diagnosis of leptospirosis is important as it gives insight into 
the extent of public health problem. Moreover, early diagnosis is particularly 
important of leptospirosis (Brown et al., 1995). The diagnosis of 
leptospirosis based only on clinical signs is difficult because these signs are 
not pathognomic. Therefore, diagnosis depends on the history, clinical signs, 
lesions and laboratory findings. In this case, selection of the appropriate 
samples in each stage of the disease for laboratory diagnosis is important 
(Faine, 1982).  
Human leptospirosis is difficult to diagnose because it presents a 
polymorphic clinical picture, and usually require laboratory confirmation 
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(Silva et al., 1997). Generally, there are three main approaches for diagnosis. 
The first is to detect leptospires in the biological fluids (blood, urine, 
cerebrospinal fluids, aqueous humour) or tissue by using dark-field 
microscopy, DNA-based techniques (DNA hyperdization, PCR), 
radioimmunoassay fluorescent antibody techniques or silver impregnation 
staining. The second is to isolate the organism by direct culture of body 
fluids or tissues or by the inoculation of laboratory animals followed by 
isolation from their blood or tissues. The third is to demonstrate antibodies 
in body fluids mainly the serum. 
1.2.6.1. Microscopic Examination 
Dark-Field Microscopy (DFM) 
Leptospires are too thin and take up conventional stains too poorly to 
be observed under the ordinary light microscope. In dark-field microscopy, 
oblique light is thrown on leptospires on a microscope slide by the use of 
special condenser, while central light is interrupted (Culling, 1963). 
Leptospires stand out as silvery threads against a dark background. It is 
essential that a dark-field microscope of good quality is used. 
Direct examination of blood (Davidson, 1971) or urine (Cordes et al.., 
1982) has been used to demonstrate the leptospires. Urine is collected from 
suspected patients – centrifuged at 3450 g for 30 minutes, and then a drop of 
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deposit under a cover slip and examined by DFM (Hodges et al., 1979). A 
positive result depends on observation of intact leptospires, which are often 
confused with pertinacious filaments known as pseudo-leptospires (Rahman 
and Macis, 1979). Therefore skill microscopist is required. Dark-Field 
Microscopy (DFM) can not determine the serovar of any leptospires seen. 
1.2.6.2. Culture 
Definitive diagnosis of leptospirosis is usually achieved by culture 
and serological identification of the infective organism (Thiermann, 1984). 
Pathogenic leptospires are fastidious organisms and obligate aerobic. 
Isolation may be attempted from blood, urine and tissues (Fletcher, 1928; 
Brown et al., 1995). 
Although culture of biological samples can give a confirmatory 
diagnosis of leptospirosis, bacteriological methods for the isolation and 
identification of pathogenic leptospiral serovars are slow, labour intensive, 
relatively insensitive and some serovars are extremely difficult to isolate. 
Hence bacteriological methods are not used for routine diagnosis (Turner, 
1970, Flint and Liardet, 1980). 
A number of media has been developed for isolation and maintenance 
of leptospires. They are either enriched with bovine albumin (Johnson and 
Harris, 1967) or rabbit serum (Fletcher, 1928). Semi solid media are used for 
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primary isolation as well as maintaining stock cultures (Ellinghausen, 1973) 
while the liquid media are necessary for growing the cultures and preparing 
the antigens for diagnosis and typing. 
1.2.6.3 Microscopic Agglutination Test (MAT) 
The microscopic agglutination test is the reference test for diagnosis 
of leptospirosis and the serological test of choice (WHO, 1967; Turner, 
1968; Cole et al., 1973; Ellis et al., 1976).  It detects antibodies at serovar 
level (Cinco et al., 1992). Microscopic agglutination test detects antibodies 
of the IgM and IgG classes and therefore should be capable of detecting of 
leptospirosis both in newly infected animals and in animals where the 
primary immune response has subsided (Morris et al., 1977). The major 
problem in the serodiagnosis of leptospirosis using MAT is the frequent 
occurrence of low and inconclusive titres. These titres may be found (a) at a 
later stage of the disease (b) during the acute stage of leptospirosis and (c) 
after a past stage infection (Hartman et al., 1986). Although MAT is 
commonly used in the diagnosis of leptospirosis, it cannot distinguish 
between recent and past infection (Bercovich, 1987). 
The MAT is an effective test with high specificity for individual 
serovars. However the test is time-consuming and requires specialized 
operator for interpretation. The test can show low sensitivity and thereby 
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necessitates the use of paired sera. MAT uses a battery of leptospires 
belonging to different serovars. This requires the maintenance of hazardous 
stock cultures and uses live organisms which create a risk of laboratory-
acquired infection. There is subjectivity in the reading of the test results 
(Cole et al., 1979; Pappas et al., 1985; Zochowiski, et al., 1987; Cho et al., 
1989; Cui et al., 1991; Winslow et al., 1997). MAT remains important 
because of the epidemiological value of knowing presumptively which 
serogroup is involved in an infection (Brown and Levett, 1997)     
1.2.6.4. Enzyme-Linked Immunosorbent Assay (ELISA) 
The enzyme-linked Immunosorbent assay (ELISA) is a serological 
test that has been used for the diagnosis of many infectious diseases e.g. 
hepatitis A (Locrarnini et al., 1979), dengue (Dittmar et al., 1979), 
toxoplasmosis (Camargo et al., 1978), brucellosis (Adam et al., 1993) and 
rubella (Garland et al., 1979). 
The test can measure IgG and IgM antibodies level in serum without 
prior fractionation by using specific anti-IgM and anti-IgG enzyme 
conjugates (Cousins et al., 1985). As well as being easier to perform, ELISA 
can easily accommodate a large number of samples and give less subjective 
results than do the microscopic agglutination test (MAT) (Winslow et al., 
1997). This test is not serovars-specific. 
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The ELISA test distinguishes between IgG and IgM response. IgM 
titers rise within 1 week of infection and peak at 14 days after infection, 
whereas IgG titers are not present until 2-3 weeks after infection and peak at 
1 month. A high IgM titer suggests acute infection. Because IgM and IgG 
antibodies will agglutinate leptospires, the MAT could be done for both, but 
the MAT more closely follows IgM titres. MAT and ELISA are based on 
detection of an immunologic response by the host. Effective tests that would 
allow detection of organisms could provide diagnosis earlier in the course of 
disease but are less reliable than MAT (Greene et al., 1998) 
Adler et al. (1980) designed ELISA system using the enzyme 
horseradish peroxidase to detect both IgM and IgG leptospiral specific 
antibodies in human sera. Adler et al. (1980) and Terpstra et al. (1983) 
reported the use of enzyme-linked Immunosorbent assay (ELISA) as a 
diagnostic test for human leptospirosis. Terpsra et al. (1983) used genus-
specific with no specificity for antibody class. Zochowski et al. (1987) tested 
urease and horseradish peroxidase ELISA to leptospiral IgM and IgG in 
human sera samples. 
  ELISA for both veterinary diagnosis and surveillance needs has been 
used. The test was used to detect antibodies against leptospiral serovars in 
different animal species, cattle (Adler et al., 1982; Cousins et al., 1985; 
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Bercovich et al., 1990; Woodward et al., 1997); Sheep (Adler et al., 1981; 
Cousins and Robertson, 1986); Dogs (Hartman et al., 1984, 1986; Weeks et 
al., 1997). 
1.2.6.5. Polymerase Chain Reaction (PCR) 
Polymerase Chain Reaction (PCR) technique was first discovered in 
early eighties and it has been introduced to the scientific community at a 
conference in 1985 (Persing, 1991). PCR is the test tube system for the DNA 
replication that follows a “target” DNA sequence to be selectively amplified 
many folds in just a few hours (Pacciarini et al., 1993). During PCR, high 
temperature is used to separate the DNA molecules into single strand, and 
synthetic sequence of single-stranded DNA (20-30 nucleotides) serve as 
primers. Two different primer sequences are used to break the target region 
to be amplified. One primer is complementary to DNA strand at the 
beginning of the target region; a second primer is complementary to a 
sequence on the opposite DNA strand at the end of the target region. To 
perform a PCR, a small quantity of the target DNA is added to a test tube 
with a buffer solution containing DNA polymerase, oligonucleotide primer, 
the four deoxynucleotide building blocks of DNA and the cofactor MgCl2. 
The PCR mixture is taken through replication cycles consisting of 
temperature and time periods. It is necessary to standardize the PCR step 
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(time and temperatures). This standardization depends mainly on the 
purpose and nature of the test. The temperature and duration of the PCR 
cycles are controlled by automated thermocycler. The reaction tubes used in 
PCR are thin walled straight sides which ease the heat transfer from the 
thermocycler to the reaction mixture. 
Strategies are required to standardize reaction reagents and to avoid 
cross contamination. The PCR is a sensitive, specific and rapid technique, 
which has been successfully applied to study genetic disorders. The assay 
could detect several micro-organisms in a variety of specimens including 
sputum, serum, cerebral fluids, urine, feases and various tissues (Demmler et 
al., 1988; Ou et al., 1988; Rosa and Schwann, 1989). 
  Recently, DNA-based techniques have been introduced in the field of 
leptospirosis. They have been demonstrated to provide a useful addition and 
alternative in identification of leptospiral strains and diagnosis of the disease 
(Thiermann et al., 1985; Van Eys et al., 1988). Polymerase chain reaction 
technique has been employed successfully to type leptospires and diagnose 
the infection (Gerritsen et al., 1991). With the introduction of PCR, rapid 
detection of a small number of leptospires in clinical samples is practical due 
to specific amplification of leptospiral DNA (Gravekamp et al., 1993). The 
first attempt to detect leptospires in urine was done by Van Eys et al., 
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(1989). They examined bovine urine seeded with hadjobovis. Urine samples 
containing up to 10 leptospires gave positive results in the PCR assay. At the 
same time 20 urine samples obtained from slaughterhouse or from cows 
were investigated using PCR assay, culture isolation and serological tests. 
Polymerase chain reaction revealed the presence of leptospires in the urine 
of all cows positive by culture or serological tests. Of the 10 serological 
negative cows, 3 were positive by PCR. Of the 13 culture negative cows, 5 
were positive by PCR. 
  Two sets of primers were derived from genomic DNA libraries of 
Leptospira interrogans serovars icterohemorrhagiae . These primers enable 
amplification by PCR of target DNA fragments from leptospiral reference 
strains belonging to all presently described pathogenic leptospiral species. 
Polymerase chain reaction detected leptospires in clinical samples in the 
period between the first appearance of clinical symptoms and when 
antibodies become detectable. The DNA polymorphism in PCR products 
deserves to be explored for the identification of causative species or even 
strains (Gravekamp et al., 1993). 
  Brown et al. (1995) evaluated PCR for the detection of leptospires in 
clinical samples from patients with acute leptospiral infection. Blood and 
urine samples from patients with leptospirosis were examined by PCR, 
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culture and serology. Samples from 44 (62%) patients with leptospirosis 
were positive PCR compared to 34 (48%) by culture. The presence of 
leptospires was demonstrated by PCR in 13 Patients before the development 
of antibodies. 10 (50%) urine samples were positive by PCR while culture 
was positive in 7 (35%) patients. PCR demonstrated the presence of 
leptospiral DNA in 20 (69%) of 29 sera and 5 (38%) of 13 urine samples 
from which no leptospires could be cultured. 
1.2.7. Leptospirosis and human renal failure 
Leptospirosis is a zooantroponosis manifested as an infectious disease 
with a severe evolution, with liver and renal failure (Luca et al 2002). 
Leptospirosis can present with a wide clinical spectrum (Turgut et al 2002). 
Typically the disease presents in broad clinical categories one of them is 
Weil`s syndrome characterized by jaundice and renal failure (World Health 
Organization 2003b). 
Renal involvement is common in leptospirosis. Clinical 
manifestations varies from urinary sediment changes to acute renal failure 
(Sitprija et al 2003).  
1.2.8. Animal Leptospirosis in Sudan 
Serological tests carried on cattle for leptospiral antibodies proved 
that 15.3% of Sudanese cattle were positive in diagnostic titers. The 
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epidemiological relationship between seropositive animals and different 
climatic conditions (rainfall, atmospheric humidity and temperature) showed 
that the most favorable areas for multiplication and spread of leptospirosis 
were those with great amount of rainfall, high humidity and hence low 
temperature; Upper Nile province (38.33%) and Equatoria province (30%). 
The effect of metrologic factors on the epidemiological process of 
leptospirosis is characterized by direct and positive correlations. (El Wali 
and Knopatkin 1984).   
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CHAPTER II 
MATERIALS AND METHODS 
2.1. Study Area 
This study was carried out in two States in Sudan: Khartoum and 
Gizera States. These two States were chosen on basis that most of the heamo 
dialysis centers in Sudan are localized in them and the renal failure patients 
come to these centers from all over the country.  
2.2. Patients 
The patients in this study were of two types: (a) Human renal failure 
patients. Some of the patients were under dialysis and some were under 
conservative treatment. The dialysis units from which human renal failure 
patients examined were: Dr. Selma Dialysis Centre (Khartoum University), 
Ahmed Gasim Hospital Dialysis Unit, Wad Medany Hospital Dialysis Unit 
and Khartoum Bahry Hospital Dialysis Unit. (b) Random patients came to 
different clinics with different clinical manifestations.  
  2.3. Samples 
  2.3.1. Urine Samples 
A total of 120 urine samples were collected from renal failure patients  
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2.3.2. Serum Samples  
A total of 299 serum samples were collected from all patients. 150 
sera were from renal failure patients while the other 149 sera were from 
random patients with different clinical manifestations.  
2.4. Culture of Urine Samples 
All urine samples were cultured for the presence of leptospires. At the 
same time all urine samples were subjected to PCR for detection of 
leptospiral DNA. 
 2.4.1. Preparation of Johnson and Seiter (JS) Medium 
 2.4.1.1. Basal Medium 
To 996 ml of double-distilled deionised (D.D) water the following 
were added: 1.0 g NaCl, 1.0 g Na2HPO4  (anhydrous), 0.3g KH2PO4  
(anhydrous), Plus the following stock solutions (Appendix.1): 1.0 ml 
NH4Cl, 1.0 ml sodium pyrovate, 1.0 ml thiamine HCl, 1.0 ml glycerol. 
The pH of the medium was adjusted to 7.4 and then distributed into 
270 ml screw caped bottles and autoclaved at 121°C for 20 min and stored at 
4°C till use. 
2.4.1.2. Albumin Supplement 
The albumin supplement was prepared by dissolving 20 g of Bovine 
Serum Albumin (BSA) fraction V (water soluble) powder in 100 ml D.D 
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water. The following stock solutions (appendix.1) were slowly added to the 
powder while stirring: 2.0 ml CaCl2,  2.0 ml MgCl2, 20 ml FeSO4, 2.0 ml 
ZnSO4,  0.2 ml CuSO4, 02.0 ml Cyanocobalamin, 25 ml Tween 80. When 
the powder is completely dissolved the pH was adjusted to 7.4 and the 
solution brought to a final volume of 200 ml by the addition of distilled 
water. The solution was then sterilized by filtration using 0.22µm filter 
(Millipore). The solution was then decanted into 30ml sterile bottles and 
stored. 
2.4.1.3. Types of Media 
2.4.1.3.1. Liquid medium 
Liquid medium was prepared by adding 30 ml of albumin supplement to 
270 ml basal medium. 
 2.4.1.3.2. Semi-solid medium 
Semi-solid medium was prepared by adding 0.5g of agar (Bacto-agar 
Difco) to 270ml of basal medium, then autoclaved at 121°C for 20 minutes, 
then cooled to 56°C and 30ml of albumin supplement were added. Medium 
was distributed aseptically in 4 ml aliquots in screw-caped Bijou bottles. All 
batches of medium were checked for bacterial contamination by incubation 
for 2 days at 37°C. 
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2.4.2. Culturing method 
Fresh midstream urine was inoculated immediately using sterile 
Pasteur pipette. 2-3 drops of undiluted urine were inoculated aseptically into 
screw-caped Bijou bottle containing 4ml semi-solid (JS) medium. 
Since urine is acidic and decreases the viability of leptospires, it was 
inoculated into medium within 2 hours after collection. 
After inoculation of urine samples, culture media were incubated at 
30°C for 8 days, and then checked for leptospiral growth using Dark-Field 
Microscope (DFM). Negative samples were checked weekly with DFM till 
day 21 after that they were considered as true negative. 
2.4.2.1 Subculturing 
Five drops of the positive cultured leptospires were sub cultured into 
liquid medium using sterile Pasteur pipette and incubated at 30°C for 8 days 
and then checked for leptospiral growth using the DFM. 
2.5. Serum samples 
All serum samples were examined by Enzyme-linked Immunosorbent 
Assay (ELISA) to demonstrate antibodies against leptospires. Also all serum 
samples were subjected to PCR to detect leptospiral DNA. 
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1.5.1. Enzyme- linked Immunosorbent Assay (ELISA) 
     ELISA was carried out using the commercial ELISA kit (SERION 
ELISA classic leptospiral IgG/IgM Kit.). The kit was containing the 
following reagents: 
1. Break apart micro titter test strip each with 8 antigen coating wells 
(altogether 96), 1 frame; the coating material is inactivated.   
2. Positive control serum. 
3. Negative control serum. 
4. Anti- human- IgG-,IgM- conjugate  
  Anti-human-IgG-, IgM, from goat (Polyclonal) conjugated to 
alkaline phosphatase, stabilized with protein stabilization solution.  
5. Washing Buffer: 
Sodium chloride solution with Tween20, 30 mM Tris.    
6.  Diluting buffer: 
Phosphate buffer with protein and Tween20.  
7.  Stopping solution: 1.2 N sodium hydroxide. 
8. Substrate  para-nitrophenylphosphate, solvent free buffer. 
2.5.2. ELISA procedure 
The ELISA procedure was done according to manufacturer instructions. 
1. Tested sera were diluted with dilution buffer 1:100 dilution. 
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2. 100µl diluted samples and ready-to-use control/ standard sera were 
pipette in the micro test wells. 
3. The samples in the micro test wells were incubated for 60 min/ 37°C 
in moist chamber. 
4. The micro test wells were washed 3 times with washing buffer. 
5. 100 µl of conjugate were pipette into the micro test wells. 
6. The micro test wells were incubated for 30min/ 30°C in moist 
chamber. 
7. The micro test wells were washed 3 times with washing buffer. 
8. 100 µl of substrate solution were pipette into the micro test wells. 
9. The micro test wells were incubated for 30min/ 30°C in moist 
chamber. 
10. 100 µl of stopping solution were pipette into the micro test wells. 
11. The extinction was read at 405 nm using spectrophotometer.  
2.6. Polymerase Chain Reaction (PCR) 
2.6.1. DNA extraction 
Genomic DNA was extracted from sera and urine samples using the 
commercial genomic DNA purification kit QIAamp DNA Mini Kit 
(QIAGEN-Germany).The extraction method of DNA was performed as 
described by the manufacturer. 
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2.6.1.1. DNA extraction from sera 
DNA extraction was performed as following: 
1. 200µl serum sample was added to the microcentrifuge tube 
2. 20µl proteinase k was pipette into the bottom of a 1.5 ml 
microcentrifuge tube. 
3. 200µl lysis buffer was added to the microcentrifuge tube and then 
mixed by pulse-vortexing for 15 seconds. 
4. The microcentrifuge tube was incubated at 56°C for 10 minutes. 
5. The microcentrifuge tube was centrifuged at 6000 × g (800 
round/min) for a short time to remove drops from the inside of the 
lid. 
6. 200µl ethanol  (96-100%) was added to the sample and then mixed 
by pulse-vortexing for 15 seconds, then , centrifuged  to remove 
drops from the inside of the lid. 
7. Carefully the mixture from step 6 was transferred to the QIAamp 
Spin Column (in a 2ml collection tube) without wetting the rim, the 
cap was closed and centrifuged at 6000 × g (8000 round/min) for 1.0 
min, the QIAamp Spin Column was placed in a new clean 2 ml  
collection tube and the tube containing the filtrate was discarded. 
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8. Carefully  the QIAamp Spin Column was opened and 500µl buffer 
AW1 (washing buffer) without wetting the rim, the cap was closed  
and centrifuged at 6000 × g (8000 round/min) for 1.0 min, the 
QIAamp Spin Column was placed in a new clean 2 ml  collection 
tube and the tube containing the filtrate was discarded. 
9. Carefully  the QIAamp Spin Column was opened and 500µl buffer 
AW2 (washing buffer) without wetting the rim, the cap was closed  
and centrifuged at full speed 20000 × g (14000 round/min) for 3min,  
10. The QIAamp Spin Column was placed in a new clean 1.5 
microcentrifuge tube and the tube containing the filtrate was 
discarded. Carefully the QIAamp Spin Column was opened and 
200µl buffer AE ( elution buffer) or distilled water was added ,then, 
incubated at room temperature ( 15-25°C) for 1.0 min, and then 
centrifuged at 6000 × g (8000 round/min) for 1.0 min,   
11. The filtrate from step 10 was containing the DNA. 
2.6.1.2. DNA extraction from urine samples 
DNA extraction was performed as following: 
1. In 1.5ml microcentrifuge tube 1.0 ml urine sample was pipette and 
centrifuged at 6000×g (8000 round/min) for 10 min, then, the 
supernatant was discharged and the pellets were washed with 1ml 
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Phosphate Buffer Saline PBS (Appendix 2) and centrifuged at 
6000×g (8000 round/min)  for 10min., then, the supernatant was 
discharged. 
2. 200µl Tissue Lysis Buffer was added to the pellets. 
Then, the procedure was done as described in (2.6.1.1) from step 2.       
2.6.2. Oligonucleotide primers 
One pair of specific primer was used, Genekam Biotechnology AG 
(Germany). The sequence of the primer was as follow: 
 G1 5’-CTG AAT CGC TGT ATA AAA GT    
 G2 5’-GGA AAA CAA ATG GTC GGA AG 
 
2.6.3. PCR Procedure  
Genekam Biotechnology AG (Germany) PCR kit was used to amplify 
leptospiral DNA in urine and serum samples. 
For specific amplification, the reaction was performed in a final 
volume of 20µl. All tubes containing DNA and all kits’ tubes were thawed 
and put on ice, then, all microtubes were marked with samples numbers and 
with +ve and –ve control. 6µl of buffer + nucleotides was added to each 
tube. Then 10µl PCR buffer was added to each micro tube and touching the 
wall of micro tube was avoided. Then 1µl of primer was added to each 
micro tube then 1µl of tube containing tag was added to each micro tube and 
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touching the wall of micro tube was avoided. Then 2µl of DNA extracted 
from samples was added with pipette tip with filter to each micro tube 
according to the label except +ve and –ve control and touching the wall of 
micro tube was avoided. The mixture was mixed thoroughly. Then 2µl of 
+ve control was added to the +ve control micro tube using a new pipette tip 
with filter, then, the micro tube was mixed thoroughly. 2µl of -ve control 
was added to the -ve control micro tube using a new pipette tip with filter, 
then, the micro tube was mixed thoroughly. The PCR programme of the 
thermocycler was run for amplification. 
2.6.4. PCR programme 
The specific amplification cycles consisted of an initial denaturation 
step at 95°C for 3 minutes; this was followed by 35 cycles of amplification 
consisting of 60 second at 95°C, 30 seconds at 55°C, 45 seconds at 72°C 
with an extension incubation at 72°C for 300 seconds.    
2.6.5. Agarose gel electrophoresis of amplified products 
The amplified products were mixed with loading buffer (Genekam 
Biotechnology AG, Germany), loaded in agarose gel and run for 
electrophoresis (80 volt/50 min) and visualized by UV light 
transilluminatoion. DNA ladder (Genekam Biotechnology AG, Germany) 
was used as DNA size marker.  
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2.7. Questionare  
For data collected, all renal failure patients in this study were 
subjected to a questionare to investigate weather some factors were 
contribute in prevalence of leptospirosis in this study or not. 
The questioner questioned the following points: 
• Age 
• Sex 
• Occupation 
• Area: from which patients came. 
• Onset of renal failure. 
• Causes of renal failure (according to the patients).   
• Contact with animal. 
2.8. Data analysis 
Microsoft Excel (Windows, 2003) and Stata 6.0 for Windows 
98/95/NT were used for data analysis. Chi-square (χ2) was used to asses the 
relationship between occurrence of leptospirosis within human renal failure 
patients and within random patients came to the clinic with different clinical 
manifestations and various factors. 
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CHAPTER III 
RESULTS 
3.1. Bacteriological examination 
From 120 renal failure patients` urine samples cultured, 16 (13.3%) 
samples revealed leptospiral growth. The isolates were demonstrated by dark 
field microscope. The grown organisms were spiral in shape and they showed 
spiral motility. The isolates were not identified to serovar level due to lack of 
hyper immune sera.    
3.2.Enzyme-Linked Immunosorbet Assay (ELISA) 
3.2.1. Renal failure patients’ sera 
From the 150 renal failure patients’ serum samples IgG to leptospires 
was detected in 18 (12.0%). 
3.2.2. Sera from patients came to the clinic with different clinical 
manifestations 
From 149 sera collected from patients came to the clinic with different 
clinical manifestations IgM to leptospires was detected in 63 (42.3%), while 
from 132 sera collected from the same group IgG to leptospires was detected in 
9 (6.8%). 
3.2.3. IgM and IgG in the two groups 
The total percentage of the positive serum samples to IgG ELISA for 
both two groups (renal failure patients’ samples and serum samples collected 
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from patients came to the clinic with different clinical manifestations) was 27 
(9.57%), while 6 samples (4%) from the group of the patients came to the clinic 
with different clinical manifestations gave positive results with both IgM and 
IgG. 
The total number of the positive sera to both IgM and IgG from the two 
groups was 84 (28.09%). 
3.2.4.1. Occurrence of leptospirosis in different areas 
3.2.4.1.1. In patients came to the clinic with different clinical 
manifestations 
3.2.4.1.1.1. Detection of IgM to leptospires in Khartoum & Gizera States 
From the 149 sera collected from patients came to the clinic with 
different clinical manifestations the positive samples to IgM in Khartoum State 
were 22 (14.77%), while the positive samples to IgM in Gizera state were 41 
(27.52%). The result is shown in (Figure 1). 
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Figure 1:  IgM to leptospires within patients came to the clinic with different clinical 
manifestations in Khartoum & Gizera States using ELISA. 
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3.2.4.1.1.2. Detection of IgG to leptospires in Khartoum & Gizera States 
From 132 sera tested, IgG to leptospires was detected in 5 samples 
(3.79%) in Khartoum State, while IgG was detected in 4 (3.03%) in the Gizera 
State. The result is shown in (Figure 2).  
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Figure 2: IgG to leptospires within patients came to the clinic with different clinical 
manifestations in Khartoum & Gizera States using ELISA. 
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3.2.4.1.2. In renal failure patients 
3.2.4.1.2.1. Detection of IgG to leptospires in different areas  
IgG was detected in 12 (8%) in Gizera State and 6 (4%) in Khartoum 
State. 
Statistically, we found that there was no significant difference (P> 0.05) 
between areas (Khartoum and Gizera States) and occurrence of leptospirosis 
within patients came to the clinic with different clinical manifestations and 
within renal failure patients. 
3.2.4.2. Occurrence of leptospirosis and sex 
3.2.4.2.1. In patients came to the clinic with different clinical 
manifestations 
3.2.4.2.1.1. Detection of IgM to leptospires 
From 149 samples, IgM was detected in 43 (28.86%) male’s samples, 
and in 20 (13.42%) female’s samples. The result is shown in (Figure 3). 
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Figure 3: IgM to leptospires in males and females within patients came to the clinic with 
different clinical manifestations. 
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3.2.4.2.1.2. Detection of IgG to leptospires 
From 132 samples, IgG was detected in 8 (6.06%) males’ samples and in 
01 (0.76%) females’ samples. The result is shown in (Figure 4). 
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Figure 4: IgG to leptospires in males and females within patients came to the clinic with 
different clinical manifestations. 
 
 47
3.2.4.2.2. In renal failure patients 
3.2.4.2.2.1. Detection of IgG to leptospires 
From 150 sera, IgG was detected in 14 (9.3%) males’ samples, and in 
4.0 (2.7%) females’ samples.  
There was no significant difference reported (P> 0.05) between sex and 
presence of leptospirosis within patients came to the clinic with different 
clinical manifestations and within renal failure patients. 
3.2.4.3. Occurrence of leptospirosis within different ages in renal failure 
patients 
150 renal failure patients were divided into 4 age groups: < 20 years 
there was 1.0 patient, the positive to IgG to leptospires were 0.0 patients. < 40 
years there were 63 patients, the positive to IgG to leptospires were 5.0 (3.3%). 
<60 years there were 57 patients, the positive to IgG to leptospires were 9.0 
(6.0%). > 60 years there were 20 patients, the positive to IgG to leptospires 
were 4.0 (2.7%).  
Statistically, there was no significant different (P>0.05) between age and 
occurrence of leptospirosis within renal failure patients. 
3.2.4.4. Occurrence of leptospirosis within different occupations in renal 
failure patients 
150 renal failure patients were divided into 4 occupational groups: 
Farmer, the positive to IgG to leptospires were 3.0 (2.0%). Educated, the 
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positive to IgG to leptospires were 4.0 (2.7%). Without work, the positive to 
IgG to leptospires was 1.0 (0.67%). Non-educated, the positive to IgG to 
leptospires were 10 (6.7%). 
Statistically there was no significant difference (P>0.05) between 
occupation and presence of leptospirosis within human renal failure patients. 
3.2.4.5. Occurrence of leptospirosis according to patient’s contact with 
animals 
According to the contact with different animal species, renal failure 
patients were divided into 2 groups: Patients in contact with different animal 
species, the positive to IgG to leptospires were 3 (2.0%), while patients with no 
contact with animal species, the positive to IgG to leptospires were 15 (10%).    
There was no significant difference (P>0.05) between contact with animals and 
occurrence of leptospirosis within human renal failure patients. 
3.3. Polymerase chain reaction (PCR) 
3.3.1. Detection of leptospiral DNA with PCR in urine samples 
Out of 120 urine samples collected from renal failure patients, the 
genomic DNA from 2 urine samples (1.7%) was amplified by PCR when the 
specific leptospiral primers were used; they produced single bands with 
molecular size of 274 base pairs (bp). Figure (5&6). 
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Figure 5: Gel Electrophoresis of PCR product obtained from urine samples of renal 
failure patients. Lanes: A (1, molecular size marker; 2, positive control; 4, 
positive PCR product; 3,5,6,7,8,9,10 and11, negative PCR products). B (1, 
molecular size markers; 2, positive control; 3,4,5,6,7,8,9,10& 11, negative PCR 
products). 
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Figure 6: Gel Electrophoresis of PCR product obtained from urine samples of renal 
failure patients. Lanes: 1, molecular size markers; 2, positive control; 9, positive 
PCR product; 3, 4, 5,6,7,8 & 10, negative PCR products) 
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3.3.2. Detection of leptospiral DNA with PCR in sera collected from renal 
failure patients: 
 None of the sera collected from renal failure patients showed positive 
results with PCR. 
3.3.3. Detection of leptospiral DNA with PCR in sera collected from 
patients came to the clinic with different clinical manifestations: 
 Out of 150 serum samples, the genomic DNA from 8 (5.3%) sera was 
amplified by PCR when the specific leptospiral primers were used, they 
produced single bands with molecular size of 274 bp. Figures (7, 8, 9, 10, 11, & 
12). 
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Figure 7: Gel Electrophoresis of PCR product obtained from serum samples of patients 
came to the clinic with different clinical manifestations. Lanes: 1, molecular 
size markers; 2, positive control; 6&8, positive PCR products; 3,4,5,7,9&10, 
negative PCR products. 
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Figure 8: Gel Electrophoresis of PCR product obtained from serum samples of patients 
came to the clinic with different clinical manifestations. Lanes: 1, molecular 
size markers; 2, positive control; 4, positive PCR products; 3,5&6, negative 
PCR products. 
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Figure 9: Gel Electrophoresis of PCR product obtained from serum samples of patients 
came to the clinic with different clinical manifestations. Lanes: 1, molecular 
size markers; 2, positive control; 9, positive PCR products; 3, 4, 5, 6, 7& 8, 
negative PCR products 
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Figure 10: Gel Electrophoresis of PCR product obtained from serum samples of patients 
came to the clinic with different clinical manifestations. Lanes: A (1, 
molecular size markers; 2, positive control; 6&8, positive PCR products; 
3,4,5,7,9,10,11,12 &13, negative PCR products). B (1, molecular size 
markers; 2, positive control; 3,4,5,6,7,8,9,10,11,12 &13, negative PCR 
products). 
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Figure 11: Gel Electrophoresis of PCR product obtained from serum samples of patients 
came to the clinic with different clinical manifestations. Lanes: A (1, 
molecular size markers; 2, positive control; 3,4,5,6,7,8,9,10,11,12 &13, 
negative PCR products). B (1, molecular size markers; 2, positive control; 10 
positive PCR product; 3,4,5,6,7,8,9,11&12, negative PCR products). 
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Figure 12: Gel Electrophoresis of PCR product obtained from serum samples of patients 
came to the clinic with different clinical manifestations. Lanes: A (1, 
molecular size markers; 2, positive control; 3,4,5,6,7,8,9,10,11,12&13, 
negative PCR products). B (1, molecular size markers; 2, positive control; 6 
positive PCR product; 3,4,5,7,8,9,10,11,12 &13, negative PCR products). 
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CHAPTER IV 
 
DISCUSSION 
 
Leptospirosis also known as “march fever” and “mud fever,” is an 
important zoonotic disease, with an important veterinary and public health 
impact (Gussenhoven et al., 1997). The disease is of high prevalence in 
tropical and subtropical regions due to favorable environmental and climatic 
factors (Adin et al., 2000; Ward 2002). Sudan is a subtropical area and 
hence the disease may be prevalent. No work was carried out on human 
leptospirosis in Sudan. Previous work on the disease was directed to animal 
leptospirosis (El Wali and Knopatkin 1984).   
  This study is the first one on human leptospirosis in Sudan. The main 
objective of this study was to investigate the disease among renal failure 
patients and among patients came to the clinic with different clinical 
manifestations. In this study, the prevalence of the disease in selected 
patients was carried based on bacterial examination, serology and detection 
of leptospiral DNA in serum and urine samples. From 120 renal failure 
patients` urine samples cultured, 16 (13.3%) samples revealed leptospiral 
growth. Although our isolates were not identified, the isolation of leptospira 
from renal failure patients is very important because it is the first time in 
Sudan to isolate leptospires from renal failure patients, on the other hand it 
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could give a new insight to the contribution of leptospirosis in renal failure 
cases in Sudan. In this study IgG was demonstrated in the serum of 18 (12%) 
renal failure patients. On the other hand, out of 120 urine samples from the 
same patients, two samples (1.65%) showed positive reaction to PCR while 
all sera were negative for PCR. The high prevalence of the disease based on 
serology among renal failure patients may indicate that leptospirosis may be 
one of the factors that contribute in human renal failure in Sudan and should 
be considered as one of the causes of the disease. Knowing that the 
incidence of renal failure was highly increased in recent years in Sudan but 
the specific causes were not fully determined and there may be many cases 
of renal failure due to leptospires. Luca et al 2002 stated that leptospirosis 
can be manifested as a severe evolution with liver and renal failure. 
Typically the disease presents in broad clinical categories one of them is 
Weil`s syndrome characterized by jaundice and renal failure (WHO 2003 a). 
Sitprija et al 2003 stated that renal involvement is common in leptospirosis 
and clinical manifestations vary from urinary sediment changes to acute 
renal failure. Although this high prevalence detected serologically, only two 
urine samples showed PCR product. This may be attributed to the shedding 
of leptospires in urine is intermittent beside the fact that the samples were 
collected from chronic renal failure patients and renal failure it self is one of 
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the last stages of leptospirosis (WHO, 2003b). Negative PCR sera may be 
due to that the patients were chronic and passed the septicemic phase of the 
disease hence the organism is no longer found in the blood.  
Random patients came to the clinic with different clinical 
manifestations showed very high prevalence (42.3%) to IgM, while the 
results with IgG ELISA showed lower prevalence which was (4%). This 
very high prevalence is surprising and needs further investigations. El Jaali, 
(2002) examined random patients came to different clinics in Malaysia with 
different clinical manifestations; he found that, IgM to leptospires was 
detected in 209 (9.5%) samples while IgG was detected in 110 (5.0%) 
samples. From all positive samples tested, 44 (2.0%) samples had both IgM 
and IgG to leptospires.   
According to the data collected from the renal failure patients we 
found that there was no significant differences between many factors (sex, 
age, areas, occupation and contact with animals) and occurrence of 
leptospirosis in this study. Although different previous studies proved that 
leptospirosis is primary an occupational disease and generally the groups at 
risk are veterinarian, abattoir workers (Campagnolo et al., 2000; Chan et al., 
1987; Hathaway et al., 1985), meet inspectors (Blackmore  et al., 1979), 
agricultural workers, sewers and mine workers and other wet rodent-infested 
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environment workers (Faine, 1982), this may be due to the fact that our 
patients were random but the mentioned studies investigated the disease 
within specific groups.  
Regarding the age and sex, our findings were disagreed with WHO 
2003c who stated that males are more expected to be exposed to leptospires 
than females and children are more susceptible, on the other hand, our 
findings were agreed with Tan, 1973 and Yersin et al 1998 who found that 
the persons of all ages and sex are equally susceptible to infection.   
In this study three techniques were used: Bacteriological examination, 
serology (ELISA) and molecular technique (PCR) and we found that ELISA 
was more efficient, sensitive, reproducible, quick, easy and cheaper test for 
diagnosis of human leptospirosis than the other tests. In bacteriological 
examination positive result depends on observation of intact leptospires, 
which are often confused with pertinacious filaments known as pseudo-
leptospires (Rahman and Macis, 1979). Therefore skill microscopist is 
required. Dark-Field Microscopy (DFM) can not determine the serovar of 
any leptospires seen, while PCR should be performed in the early stages 
because leptospires are not found in the blood stream in the late stages of the 
disease and found just during the septicemic phase of the disease. 
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Conclusion 
(i) Human leptospirosis is endemic infection in Sudan; moreover, it is 
clear that it is one of the causes of human renal failure. 
(ii) Bacteriological examination was not very useful in the diagnosis of 
human leptospirosis. 
(iii) Enzyme-linked Immunosorbent assay was sensitive, reproducible, 
quick, easy and cheaper test for diagnosis of human leptospirosis. 
(iv) PCR has the potential to be useful method for detecting leptospires 
in serum in the early stages of the disease. 
Recommendations 
(i) The results obtained in this study can be used for further 
development of the ELISA kit for diagnosis of human 
leptospirosis. 
(ii)  In this study application of PCR on serum samples collected from 
renal failure patients was tried but results were not obtained. 
Further trails for detection of organism DNA in serum should be 
tried. 
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(iii) Study of the prevalence of leptospiral infection in different 
occupational groups in Sudan like farmers and abattoir workers 
would be useful. 
(iv) Serotyping of isolated leptospires would be useful to determine the 
serovars.    
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APENDIXES 
Appendix 1 
     Preparation of Stock Solution 
Fresh stock solution was prepared for each batch of medium as follow: 
Chemicals                             g/100 ml H2O 
NH4Cl (anhydrous)…………………………….…… 25 
CaCl2.2H2O……………………………………........ 1.5 
MgCl2.6H2O……………………………………....... 1.5 
FeSO4.7H2O …………………………………..…… 0.5 
ZnSO4.7H2O  ……………………………..….……. 0.4 
CuSO4.5H2O  ………… ……………………..……. 0.3 
Sodium pyrovate …………………………...…......... 10 
Thiamine HCl……………………………..………..  0.5 
Cyanocobalamin………………………..…….........  0.02 
                                                ml/100 ml H2O 
Glycerol…………………………………….….......    10 
Tween 80……………………………………….......   10 
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Appendix 2 
Preparation of Phosphate Buffer Saline 
NaCl ……………………………………………………….. 8.00 g 
KCl ………………………………………………………... 0.2 g 
Na2HPO4. …………………………………………………... 1.4 g 
KH2PO4 . …………………………………………………… 0.24 g 
Distilled water ……………………………………………... 1.0 litre 
The above chemicals were mixed throughly and then the pH was adjusted 
to 7.4 and autoclaved at 121°C for 20 minutes.  
    
 
 
Appendix 3 
Preparation of Electrophoresis Buffer 
Tris Acetic Acid EDTA (TAE) (Bio rad, Germany) was used as 
electrophoresis buffer. 
(1×TAE) was prepared using 20 ml (50×TAE) + 980ml distilled water. 
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Appendix 4 
Preparation of Ethidium Bromide (10mg/ml) 
     Ethidium bromide ……………………………………….. 1 g 
     Distilled water      ……………………………………….. 100 ml 
       The solution was stirred on magnetic stirrer for several hours to ensure 
the complete dissolving of the dye. The container was warped with 
aluminium foil and stored at room temperature.  
 
 
 
Appendix 5 
Preparation of the Agarose Gel  
1% agarose gel was prepared using 1.2 g agarose (Sigma-Germany) in 
120 ml (1×TAE) (Apendix 4) with 6 µl ethidium bromide staining.       
 
 
     
  
 
